SM Jugl

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study

Laura C. Coates, Dafna D. Gladman, Peter Nash et al. · Arthritis Research & Therapy · 2018 · 40 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Matching Adjusted Indirect Comparisons To Assess Comparative Effectiveness Of Therapies: Usage In Scientific Literature And Health Technology Appraisals

Howard Thom, SM Jugl, E. Palaka et al. · Value in Health · 2016 · 26 citations · Full text

Pharmacy, Pharmacoeconomics, Comparative Effectiveness Research +16

Unmet needs in psoriatic arthritis patients receiving immunomodulatory therapy: results from a large multinational real-world study

Rieke Alten, Philip G. Conaghan, Vibeke Strand et al. · Clinical Rheumatology · 2019 · 23 citations

Life Sciences, Clinical Sciences, Immunology +11

Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study

Atul Deodhar, Vibeke Strand, Philip G. Conaghan et al. · BMC Rheumatology · 2020 · 13 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +17